Acute lymphoblastic leukemia (ALL), the most common cancer compartment (CD34 + Lin − ) that in normal hematopoiesis con- 
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− that excludes leuAcute lymphoblastic leukemia (ALL), the most common cankemic blasts and contains stem cells in normal hematopoiesis cer in childhood, is characterized by clonal proliferation of was evaluated. The molecular cytogenetic properties of lymphoblasts. It is generally accepted that accumulation of phenotypically defined subpopulations can be assessed using genetic abnormalities in lymphoid progenitors results in fluorescence in situ hybridization. 10, 11 Hyperdiploidy is a abnormal clonal expansion manifested by elevated numbers common cytogenetic abnormality in pediatric ALL. 31 We used of transformed lymphoblasts. The progenitor population from repeat-sequence and region-specific DNA probes to deterwhich leukemic lymphoblasts originate is controversial. Derimine whether cells sorted from the CD34 + 33 − 38 − 19 − compartvation of leukemic blasts from a lymphoid committed progeniment of 19 newly diagnosed ALL patients, one remission case, tor cell has been suggested in some studies, 1,2 whereas a stem and one case at relapse contained cytogenetic abnormalities cell origin for ALL has been postulated in others. [3] [4] [5] Increased that were also present in the leukemic lymphoblasts. understanding of the ontogeny and the hierarchical developOur data demonstrate that cytogenetically aberrant cells are mental potential of ALL in children is relevant for mechanistic present in the CD34 + Lin − compartment in some pediatric ALL studies of leukemogenesis and may have implications for specimens. These data may indicate two models of leukemic prognosis. 6 For example, chemo-and radioresistant properties evolution: in one, cytogenetically aberrant lymphoblasts of stem cells are likely to differ from more mature proevolve from aberrant cells in a phenotypically defined primigeny, 7-9 thus variations among ALL patients in the involvetive compartment, and in the other the transforming event ment of primitive cells may contribute to variable treatment occurs in the blast population. response. We applied a combined phenotype/genotype approach using multivariate flow sorting and fluorescence in situ hybridization to determine whether cytogenetically Materials and methods aberrant cells in ALL are present in a phenotypically defined jects Research at the University of California, San Francisco.
packet in Normal-C mode to ensure maximal purity (over 98% 33 Briefly, cellular DNA was denatured by heating the slides containing cells at 72°C for 3 min in 70% formamide used as controls for non-specific immunofluorescence. After washing as described previously, 10 cells were incubated with (v/v) in 2 × SSC pH 7.0 (0.3 M NaCl, 0.03 M NaCitrate). DNA probes were denatured in a solution containing 50% formapropidium iodide (PI, 10 g/ml, 5 min, room temperature; Sigma) to label dead cells and then fixed in paraformaldehyde mide, 10% dextran sulfate, 2 × SSC solution at 72°C for 5 min.
Ten microliters of the hybridization mix containing fluorescent (0.1%) prior to sorting.
Flow cytometric analysis and sorting were performed on a DNA probe (s) were added to each cell spot. A coverslip was placed on the spot and sealed with rubber cement to prevent FACStar Plus Cell Sorter (Becton Dickinson) equipped with two argon-ion lasers (Coherent, Palo Alto, CA, USA) tuned to evaporation. Following overnight incubation at 37°C, the slides were washed three times in 50% formamide in 2 × SSC, 488 nm (primary laser) and to 351-364 nm (secondary laser). Small debris and cell aggregates were excluded by forward then twice in 2 × SSC, 46°C and once in 4 × SSC at room temperature. Cells were counterstained with DAPI (0.4 g/ml 4,6-and side light scatter measurements, and doublets were excluded using forward scatter pulse width and area measurediamidino-2-phenylindole; Sigma) in an anti-fade solution. 34 Cellular hybridization domains were identified visually ments. FITC and PE-linked immunofluorescence emissions from the primary laser excitation were collected through using a fluorescence microscope. The frequency of cells carrying two or more hybridization domains/labeled probe was 530 nm (±30 nm) and 575 nm (±26 nm) bandpass filters, respectively. Hoechst and PI emissions from secondary laser measured in each sorted subpopulation. In some cases, two different DNA probes specific for aberrant chromosomes were excitation were collected through 435 nm (±50 nm) bandpass and 620 nm longpass filters, respectively.
hybridized. The number of hybridization domains per cell is considered to be proportional to the copy number of the labEstimates of the frequency of discriminated subpopulations and gates used for cell sorting were described previously. Aneusomy frequency in normal controls and statistical analyses ers were set at the first decade of the FITC and PE parameters, and photo multiplier tube voltages adjusted such that gated specific regions contained Ͻ0.01% of viable nucleated cells
We used data from three normal control subjects to establish baseline frequencies for cells with Ͼ2 hybridization domains. from the isotype control sample. Fluorescence compensation was established using single fluorochrome positive controls.
The baseline/background frequency of cells with Ͼ2 hybridization domains was determined for each DNA probe used in Rectangular regions within the positive quadrant boundaries were used to sort three compartments (see Results section)
analyses of the leukemic specimens. 
The stringent sort regions, normal healthy subjects and hybridized with repeat-sequence or region-specific DNA probes. The frequency of aneusomic set 5-15% away from the quadrant boundaries, were used to minimize contamination from adjacent cell subpopulations cells in normal marrow subpopulations (described in the Results section) follows a binomial distribution. Thus, the during the sort. Cells from these regions were sorted into wells on Teflon-coated glass microscope slides using a two-drop upper 95% confidence limit for the proportion of cytogenet-
Aberrant cells in CD34
+ Lin − compartment in ALL CA Quijano et al ically aberrant cells was calculated for each leukemic speciprobes for selected chromosomes in the leukemic karyotype were used to identify cytogenetically aberrant cells in sorted men. A locally weighted least squares fit was used in correlative analyses to estimate statistical significance.
subpopulations (see Table 1 ).
Flow cytometric analysis and sorting

Results
Patient and specimen characteristics
Subpopulations from immunofluorescently labeled leukemic and normal marrow specimens were discriminated flow cytometrically and sorted for FISH. Nucleated viable cells from Clinical and laboratory data were obtained from 20 ALL cases in children ages 0.5-15 years. Nineteen marrow specimens at cryopreserved marrow specimens were considered to be PI − and HO + (Figure 1a ; Region 2). A subpopulation with elevated diagnosis and one at relapse were evaluated. At 28 days after induction therapy, specimen 622 was also evaluated in HO fluorescence intensity (a) most likely represents hyperdiploid cells that were also observed in the karyotype of speciremission. Table 1 shows the FAB classification, WBC/mm 3 , blast frequency in the marrow, and the leukemic karyotype.
men No. 11 at diagnosis. An isotype control was used to establish levels of non-specific fluorescence above which cells Fifteen of 19 ALL were classified as L1; four were L2. Blast frequencies ranged from 40-99% in the diagnosis/relapse were considered immunofluorescently labeled (Figure 1b) . The quadrant boundaries used to estimate the frequency of marrows and comprised Ͻ5% of the remission specimen. All but two leukemias were considered to be B lineage ALL + Lin + cells, respectively, and encompass a small area of the designated phenotype to ensure purity of the lations was based upon the bone marrow karyotype at diagnosis or at relapse. Repeat-sequence or region-specific DNA sorted population. 
The frequency of CD34
+ cells and the relative fraction of several of the leukemias containing fewer than 0.01% CD34 + Lin − cells. The relative fraction of the CD34 + Lin + com-CD34 + Lin − and CD34 + Lin + subpopulations in leukemic and normal marrow specimens were measured ( Table 2 ). In marpartment varied among patients; it ranged from 0.4-11.6% in CD34 − leukemias and 25.4-96.5% in CD34 + leukemias. row specimens from three pediatric patients without leukemia, the CD34 + fraction ranges from 4 to approximately 17% (mean 7.6%). Leukemic specimens with more than 20% leu-FISH analysis of sorted cell populations kemic blasts were considered to be CD34 + leukemias. In 11/19 (58%) leukemias at diagnosis the CD34 + fraction comThe fraction of cytogenetically aberrant cells in sorted prised 25-96% of the marrow specimen. The CD34 − leukemsubpopulations from leukemic specimens was measured using ias contained between 0.5 and 14.1% CD34 expressing cells.
FISH. Chromosome or regional DNA sequence gains in Specimens 681, 751, 8, 10, 12, and 19 contained fewer than interphase cells in sorted populations were identified using 6% CD34
+ cells, although the blast frequency in these cases DNA probes selected for each individual karyotype (see Table  approximates 72-99%. The fraction of CD34
+ Lin − cells in 1). The background aneusomy frequency above which cells both normal and leukemic specimens was less than 6%, with are classified as cytogenetically aberrant was established by quantifying the frequency of cells showing more than two and 10 were cytogenetically aberrant, although fewer than 5% between adult AML and pediatric ALL reflect differences among adults and children or between myeloid and lymphof the cells in those samples expressed CD34. The frequency of cytogenetically aberrant CD34 + Lin − cells was associated oid leukemias. Transformation of cells in a primitive compartment has with CD34 expression on leukemic blasts; however, the correlation coefficient (r = 0.51; 95% CI, 0.07, 0.78) was not statbeen suggested by Greaves 6,36 although other data based upon clonality measurements find little evidence for involveistically significant. ment of multipotential stem cells in ALL. 1 Identification of erythroid cells that carry cytogenetic aberrations present in the lymphoblast clone in the marrow of one of six patients with Discussion ALL 37 may suggest derivation of the erythroid cell from a cytogenetically aberrant non-lymphoid precursor with multipotenThe CD34 +
38
− population comprises a small fraction of both normal and leukemic marrow. Approximately 0.01-0.05% of tial capabilities or indicate lineage switch. Co-expression of lymphoid and myeloid antigens on 5-20% of ALL blasts 27, 31, 38 normal marrow cells concomitantly express CD34 and lack CD38. 10, 17, 19, 35 In a recent study of pediatric ALL cases, only may indicate transformation of a primitive cell. However, extrapolation of leukemic blast phenotypes to counterpart 2% (1/49) of the specimens were considered to be CD34 + 38 − leukemias. 24 In our study, CD19 and CD33 were included subpopulations in normal hematopoiesis may reflect aberrant antigen expression/lineage infidelity and thus may not be with CD38 to further subdivide the CD34 subpopulation and to increase the purity of the sorted subpopulations by providentirely valid. 39 Our data are based upon sorting a primitive population defined on the basis of CD34, CD33, CD38 and ing a negative discriminant for leukemic cells. Our data indicate that the CD34
+
Lin
− compartment comprises only a minor CD19 expression, regardless of the immunophenotype of the leukemic blasts, and indicate that ALL blasts in some patients fraction (Ͻ6%) of the leukemic marrow in all specimens at diagnosis/relapse. These findings are consistent with the low originate from a cell contained within a phenotypically defined (CD34 (Figure 3 ). In contrast, the CD34 + Lin + compartment in all patients contained aberrant cells at fredefined progenitor subpopulations.
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The clinical significance of inter-patient variation in the frequencies of 15-90%, even though 8/19 patients were CD34 − leukemias (ie Ͻ20% CD34 + cells). These data suggest that quency of aberrant cells in the CD34 + Lin − compartment in ALL is unknown. It has been postulated that leukemias that cells with aberrant genotypes are found in the CD34 compartment regardless of whether CD34 is expressed on the majority originate in a stem/precursor compartment may be more difficult to eradicate than those in which the transforming event of leukemic blasts. A remission specimen did not contain cytogenetically aberrant cells. The specimen collected at occurs at a later maturational stage. 6 However, some lymphoid leukemias that originate in the lineage-committed comrelapse contains aberrant cells in both the CD34 + Lin − and CD34 + Lin + subpopulations which suggests either that relapse partment may have a worse prognosis. 41 Differences in cycling status, drug efflux and influx in stem cells and originates in the CD34 + Lin − compartment or that cells in both compartments were incompletely eradicated. Further analysis differentiated cells may contribute to variable treatment outcome among leukemic patients. 6 In our study, 26% of speciof paired specimens at diagnosis and relapse will be required to determine whether leukemias at diagnosis and relapse origmens contain cytogenetically aberrant CD34 + Lin − cells, which is similar to the 20% failure rate commonly associated with inate in the same compartment.
Our data demonstrating that cytogenetically aberrant cells average risk pediatric ALL. In the series of patients described in this study, 4/19 treated patients (3, 16,19 and 751) relapsed, are present in the CD34 + Lin − compartment in pediatric ALL contrast with those reported for acute myeloid leukemia and three (3, 16 and 19) of these children died within 2 years. These three patients carried cytogenetically aberrant (AML).
10, 11 We demonstrated previously that aneusomic cells were present in the CD34 + Lin − compartment in 15/15 speci-CD34 + Lin − cells. Patient 6 died 2 months after diagnosis having received no therapy. The other patients have not yet mens suggesting involvement of an early precursor in all adult patients with aneusomic AML/MDS. It is unclear whether the relapsed (20-79 months follow-up). Additional analysis in a larger study group will be required to assess the prognostic differences in involvement of the CD34 + Lin − compartment with this study: Peter C Nowell, MD (University of
